Regenerative Cell Therapy for Rotator Cuff

About InGeneron

InGeneron is a private, clinical-stage biotech focused on developing point-of-care regenerative cell therapies for orthopedic injuries. Its core technology, the Transpose Ultra® system, enzymatically processes a patient's own adipose tissue to isolate a mixture of regenerative cells for immediate re-injection. With a lead program in rotator cuff tendinopathy and others in osteoarthritis, the company is pursuing a rigorous FDA approval pathway to address a large market of patients with chronic musculoskeletal conditions, differentiating itself from unregulated stem cell clinics.

Therapeutic Areas